HSTM Quote, Financials, Valuation and Earnings

HealthEquity has a net margin of 6.59% compared to HealthStream's net margin of 8.46%. HealthStream's return on equity of 5.72% beat HealthEquity's return on equity of 4.59%.

HealthStream has a consensus price target of $35.00, signalling upside risk potential of 9.72%. On the other hand HealthEquity has an analysts' consensus of $113.29 which suggests that it could grow by 26.97%. Given that HealthEquity has higher upside potential than HealthStream, analysts believe HealthEquity is more attractive than HealthStream.

HealthStream has a beta of 0.374, which suggesting that the stock is 62.556% less volatile than S&P 500. In comparison HealthEquity has a beta of 0.617, suggesting its less volatile than the S&P 500 by 38.323%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.36%. HealthEquity offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthStream pays 17.01% of its earnings as a dividend. HealthEquity pays out -- of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $74.2M, which are smaller than HealthEquity quarterly revenues of $311.8M. HealthStream's net income of $4.9M is lower than HealthEquity's net income of $26.4M. Notably, HealthStream's price-to-earnings ratio is 48.33x while HealthEquity's PE ratio is 81.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 3.34x versus 6.60x for HealthEquity. Usually stocks with elevated PS ratios are considered overvalued.

Schrodinger has a net margin of 6.59% compared to HealthStream's net margin of -45.54%. HealthStream's return on equity of 5.72% beat Schrodinger's return on equity of -38.87%.

HealthStream has a consensus price target of $35.00, signalling upside risk potential of 9.72%. On the other hand Schrodinger has an analysts' consensus of $30.80 which suggests that it could grow by 49.52%. Given that Schrodinger has higher upside potential than HealthStream, analysts believe Schrodinger is more attractive than HealthStream.

HealthStream has a beta of 0.374, which suggesting that the stock is 62.556% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.624, suggesting its more volatile than the S&P 500 by 62.426%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.36%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthStream pays 17.01% of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $74.2M, which are smaller than Schrodinger quarterly revenues of $88.3M. HealthStream's net income of $4.9M is higher than Schrodinger's net income of -$40.2M. Notably, HealthStream's price-to-earnings ratio is 48.33x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 3.34x versus 7.21x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

Simulations Plus has a net margin of 6.59% compared to HealthStream's net margin of 1.09%. HealthStream's return on equity of 5.72% beat Simulations Plus's return on equity of 4.58%.

HealthStream has a consensus price target of $35.00, signalling upside risk potential of 9.72%. On the other hand Simulations Plus has an analysts' consensus of $49.40 which suggests that it could grow by 105.83%. Given that Simulations Plus has higher upside potential than HealthStream, analysts believe Simulations Plus is more attractive than HealthStream.

HealthStream has a beta of 0.374, which suggesting that the stock is 62.556% less volatile than S&P 500. In comparison Simulations Plus has a beta of 0.894, suggesting its less volatile than the S&P 500 by 10.602%.

HealthStream has a quarterly dividend of $0.03 per share corresponding to a yield of 0.36%. Simulations Plus offers a yield of 1% to investors and pays a quarterly dividend of $0.06 per share. HealthStream pays 17.01% of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

HealthStream quarterly revenues are $74.2M, which are larger than Simulations Plus quarterly revenues of $18.9M. HealthStream's net income of $4.9M is higher than Simulations Plus's net income of $206K. Notably, HealthStream's price-to-earnings ratio is 48.33x while Simulations Plus's PE ratio is 60.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthStream is 3.34x versus 6.55x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.